Dr. Lauren Harshman
Claim this profileStudies Renal Cell Carcinoma
Studies Kidney Cancer
1 reported clinical trial
2 drugs studied
Area of expertise
1Renal Cell Carcinoma
Stage II
Stage I
2Kidney Cancer
Stage II
Stage I
More about Lauren Harshman
Clinical Trial Related8 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Lauren Harshman has experience with
- Nephrectomy
- Nivolumab
Breakdown of trials Lauren Harshman has run
Renal Cell Carcinoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lauren Harshman specialize in?
Lauren Harshman focuses on Renal Cell Carcinoma and Kidney Cancer. In particular, much of their work with Renal Cell Carcinoma has involved Stage II patients, or patients who are Stage I.
Is Lauren Harshman currently recruiting for clinical trials?
No, Lauren Harshman is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Lauren Harshman has studied deeply?
Yes, Lauren Harshman has studied treatments such as Nephrectomy, Nivolumab.
What is the best way to schedule an appointment with Lauren Harshman?
Apply for one of the trials that Lauren Harshman is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.